A phage-display technology was used to produce a single-chain Fv antib
ody fragment (scFv) from the 30AA5 hybridoma secreting anti-glycoprote
in monoclonal antibody (MAb) that neutralizes rabies virus. ScFv was c
onstructed and then cloned for expression as a protein fusion with the
g3p minor coat protein of filamentous phage. The display of antibody
fragment on the phage surface allows its selection by affinity using a
n enzyme-linked immunosorbent assay (ELISA); the selected scFv fragmen
t was produced in a soluble form secreted by E. coli. The DNA fragment
was sequenced to define the germline gene family and the amino-acid s
ubgroups of the heavy (V-H) and light (V-L) chain variable regions. Th
e specificity characteristics and neutralization capacity of phage-dis
played and soluble scFv fragments were found to be identical to those
of the parental 30AA5 MAb directed against antigenic site II of rabies
glycoprotein. Phage-display technology allows the production of new a
ntibody molecule forms able to neutralize the rabies virus specificall
y. The next step could be to engineer and produce multivalent and mult
ispecific neutralizing antibody fragments. A cocktail of multispecific
neutralizing antibodies could contain monovalent, bivalent or tetrava
lent scFv fragments, for passive immunoglobulin therapy. (C) 1997 Else
vier Science B.V.